[{"indications": "Indications\u00a0\n(From Levetiracetam: British National Formulary)\nLevetiracetam", "name": "LEVETIRACETAM", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "4 Central nervous system", "4.8 Antiepileptic drugs", "4.8.1 Control of the epilepsies", "Levetiracetam", "LEVETIRACETAM"], "cautions": "Cautions\u00a0avoid abrupt withdrawal; interactions: Appendix 1 (levetiracetam)", "side-effects": "Side-effects\u00a0anorexia, weight changes, abdominal pain, nausea,\r\nvomiting, dyspepsia, diarrhoea, cough, drowsiness, amnesia, ataxia,\r\nconvulsion, dizziness, headache, tremor, hyperkinesia, malaise, impaired\r\nattention, aggression, agitation, depression, insomnia, anxiety, irritability,\r\npersonality disorder, thrombocytopenia, myalgia, diplopia, blurred\r\nvision, rash; also reported pancreatitis, hepatic\r\nfailure, paraesthesia, confusion, psychosis, suicidal ideation, leucopenia,\r\nneutropenia, pancytopenia, alopecia, toxic epidermal necrolysis, Stevens-Johnson\r\nsyndrome", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/89422.htm", "doses": ["Monotherapy of focal seizures, by mouth or by intravenous infusion, adult and child over\r\n16 years, initially 250\u00a0mg once daily increased after 1\u20132 weeks to\r\n250\u00a0mg twice daily; thereafter, increased according to response in\r\nsteps of 250\u00a0mg twice daily every 2 weeks; max. 1.5\u00a0g twice daily", "Adjunctive therapy of focal seizures, by\r\nmouth, adult and child over 12 years, body-weight over 50\u00a0kg, initially\r\n250\u00a0mg twice daily, increased by 500\u00a0mg twice daily every 2\u20134 weeks;\r\nmax. 1.5\u00a0g twice daily; child over\r\n6 months, body-weight under 50\u00a0kg, initially 10\u00a0mg/kg once daily,\r\nincreased by max. 10\u00a0mg/kg twice daily every 2 weeks; max. 30\u00a0mg/kg\r\ntwice daily; child 1\u20136 months, initially\r\n7\u00a0mg/kg once daily, increased by max. 7\u00a0mg/kg twice daily every 2\r\nweeks; max. 21\u00a0mg/kg twice daily", "By intravenous infusion, adult and child over 12 years, body-weight\r\nover 50\u00a0kg, initially 250\u00a0mg twice daily, increased by 500\u00a0mg twice\r\ndaily every 2\u20134 weeks; max. 1.5\u00a0g twice daily; child over 4 years, body-weight under 50\u00a0kg, initially 10\u00a0mg/kg once daily,\r\nincreased by max. 10\u00a0mg/kg twice daily every 2 weeks; max. 30\u00a0mg/kg\r\ntwice daily", "Adjunctive therapy of myoclonic seizures and tonic-clonic seizures, by mouth or by intravenous infusion, adult and child over 12 years, body-weight over 50\u00a0kg, initially 250\u00a0mg twice daily,\r\nincreased by 500\u00a0mg twice daily every 2\u20134 weeks; max. 1.5\u00a0g twice\r\ndaily; child 12\u201318 years, body-weight\r\nunder 50\u00a0kg, initially 10\u00a0mg/kg once daily, increased by max. 10\u00a0mg/kg\r\ntwice daily every 2 weeks; max. 30\u00a0mg/kg twice daily", "If switching between oral therapy and intravenous therapy (because\r\noral route temporarily unavailable), by intravenous infusion, same as established oral dose", "Levetiracetam doses in BNF may differ from\r\nthose in product literature"], "pregnancy": "Pregnancy\u00a0see Pregnancy"}]